missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SYT12 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA552771
This item is not returnable.
View return policy
Description
Immunogen sequence: LLSLSYLPTA ERLTVVVVKA KNLIWTNDKT TADPFVKVYL LQDGRKMSKK KTAVKRDDPN PVFNEAMIFS VPAIVLQDLS LRVTVAESSS DGRGDNVGHV IIGPSASGMG TTHWNQMLAT LRRPVSMWHA V Highest antigen sequence identity to the following orthologs: Mouse - 96%, Rat - 98%.
This gene is a member of the synaptotagmin gene family and encodes a protein similar to other family members that mediate calcium-dependent regulation of membrane trafficking in synaptic transmission. Studies of the orthologous gene in rat have shown that the encoded protein selectively modulates spontaneous synaptic-vesicle exocytosis and may also be involved in regulating calcium independent secretion in nonneuronal cells. Alternative splicing results in multiple transcript variants. The gene has previously been referred to as synaptotagmin XI but has been renamed synaptotagmin XII to be standard with mouse and rat official nomenclature.
Specifications
| SYT12 | |
| Polyclonal | |
| Unconjugated | |
| SYT12 | |
| Srg1; synaptotagmin 12; synaptotagmin XII; Synaptotagmin12; Synaptotagmin-12; synaptotagmin-related gene 1 protein; SynaptotagminXII; synaptotagmin-XII; Syt XII; SYT11; Syt12; SYT-12; Sytr1; SytXII | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 91683 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin) | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q8IV01 | |
| SYT12 | |
| Recombinant protein corresponding to Human SYT12. Recombinant protein control fragment (Product #RP-90446). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction